A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...
After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...
One life was saved for every 456 men invited for a prostate cancer screening, the study found. View on euronews ...
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights from ...